ストックスクリーナーアプリを入手
7.06
0.14%
-0.01
アフターアワーズ：
7.06
前日終値:
$7.07
開ける：
$7.08
24時間の取引高:
79,179
Relative Volume:
0.26
時価総額：
$351.94M
収益：
$13.55M
当期純損益:
$-25.32M
株価収益率:
-13.03
EPS:
-0.542
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+4.13%
1か月 パフォーマンス:
-5.11%
6か月 パフォーマンス:
+46.17%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$6.73
$7.405
1週間の範囲:
$6.13
$7.74
52週間の値動き範囲:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Compare CV vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
7.06 | 352.44M | 13.55M | -25.32M | 0 | -0.542 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-28 | 開始されました | Roth Capital | Buy |
| 2025-07-28 | 開始されました | The Benchmark Company | Speculative Buy |
Capsovision Inc (CV) 最新ニュース
CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 - GlobeNewswire
CapsoVision (CV) price target decreased by 16.00% to 10.71 - MSN
CapsoVision (CV) 2026 proxy: director elections, Baker Tilly ratification and pay - Stock Titan
Capsule Endoscope Systems Market Climbs to USD 0.6 Billion - openPR.com
CapsoVision (CV) Stock Outlook | Q4 2025: EPS Tops ViewsOpen Stock Picks - Newser
CapsoVision targets 510(k) submission for Gen 2 colon capsule and AI module in Q3 2026 as commercial adoption accelerates - MSN
CapsoVision And 2 Other Growth Stocks With Significant Insider Ownership - Yahoo Finance
CV (CapsoVision) reports far narrower Q4 2025 loss than estimates, shares stay flat in today’s trading.Net Margin - Cổng thông tin điện tử Tỉnh Sơn La
[EFFECT] CapsoVision, Inc SEC Filing - Stock Titan
CapsoVision (NASDAQ: CV) registers 2.87M PIPE shares for resale - Stock Titan
CapsoVision (CV) Stock Initiates Position (Froths) 2026-04-18Company Analysis - Cổng thông tin điện tử tỉnh Tây Ninh
CapsoVision (CV) Stock Signal Based Trade (+11.30%) 2026-04-18Stock Distribution - Cổng thông tin điện tử Tỉnh Sơn La
Capsovision Incfiles prospectus for resale of 2,867,089 common shares by selling stockholdersSEC filing - marketscreener.com
Existing holders of CapsoVision (NASDAQ: CV) register 2.87M PIPE shares for resale - Stock Titan
Ching Hang Shen Net Worth (2026) - GuruFocus
CapsoVision (CV) ownership: Shen Ching Hang holds 6.40M shares, Star One indirect - Stock Titan
CapsoVision, Inc. (NASDAQ:CV) Sees Significant Increase in Short Interest - MarketBeat
CapsoVision Inc PE Ratio (TTM) & PE Ratio (TTM) ChartsCV - GuruFocus
CapsoVision (CV) Schedule 13G/A: CID group, Altenza and individuals report ≤5% holdings - Stock Titan
Is CapsoVision (CV) Stock Attractive Now | Price at $7.32, Down 1.61%Upside Potential - Newser
Earnings Preview: CapsoVision to Report Financial Results Post-market on March 26 - Moomoo
CV Stock Analysis: CapsoVision Inc. medtech logs double digit daily gain at 7.44 - Cổng thông tin điện tử tỉnh Lào Cai
CV Stock Analysis: CapsoVision Inc Falls 8.78 Percent to Close at 6.65 a Share - Newser
Major CapsoVision (CV) holder Shen Ching Hang reports large direct and indirect stake - Stock Titan
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Grows By 35.2% - MarketBeat
Benchmark cuts CapsoVision stock price target to $10 on delayed timeline By Investing.com - Investing.com Australia
Benchmark cuts CapsoVision stock price target to $10 on delayed timeline - Investing.com Australia
CapsoVision (NASDAQ:CV) Price Target Lowered to $10.00 at Benchmark - MarketBeat
CapsoVision 2025 Financial Performance Review - AlphaStreet
CapsoVision revenue up 13% to USD 3.9M in Q4 2025 - Medical Buyer
CapsoVision’s CapsoCam: 360° Panoramic AI-Powered Capsule Endoscopy Solution Expanding Global GI Diagnostics Market 2324323344 - Minichart
Large CapsoVision (CV) holder discloses direct and trust share stakes - Stock Titan
CapsoVision Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CapsoVision Q4 2025 sees revenue growth, stock dips - Investing.com Australia
CapsoVision Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: CapsoVision Q4 2025 sees revenue growth, stock dips By Investing.com - Investing.com South Africa
CapsoVision Inc reports results for the quarter ended September 30Earnings Summary - TradingView
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
CV: AI-powered capsule endoscopy drives growth and innovation in noninvasive GI screening - TradingView
CapsoVision 10-K: Revenue $13.6M, EPS $(1.03) — Annual Results - TradingView
CapsoVision (NASDAQ: CV) flags going concern while advancing AI colon capsule - Stock Titan
CapsoVision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
CapsoVision Faces Deadline to Turn Capital Into Profit Before Runway Collapses - Bitget
CapsoVision (NASDAQ: CV) grows 2025 revenue 15% as net loss widens - Stock Titan
CapsoVision, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
CapsoVision Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Capsovision Inc (CV) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.93%
大文字化:
|
ボリューム (24 時間):